CN101244209A - Medicament for preventing or treating cardiovascular and cerebrovascular diseases - Google Patents
Medicament for preventing or treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN101244209A CN101244209A CNA2008100492636A CN200810049263A CN101244209A CN 101244209 A CN101244209 A CN 101244209A CN A2008100492636 A CNA2008100492636 A CN A2008100492636A CN 200810049263 A CN200810049263 A CN 200810049263A CN 101244209 A CN101244209 A CN 101244209A
- Authority
- CN
- China
- Prior art keywords
- parts
- shares
- blood
- treatment
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug for preventing or treating cardiovascular and cerebrovascular diseases, which is made of a plurality of natural active pharmaceutical ingredients in weight account as follows: persimmon clayx 25 to 30 shares, haw 5 to 15 shares, danshen root 5 to 10 shares, Rhizoma Gastrodiae 5 to 15 shares, notoginseng 5 to 10 shares, Lobed Kudzuvine Root 5 to 12 shares, tuber fleeceflower 5 to 15 shares, fruit of common flowering quince 1 to 6 shares and hairy deerhorn 0.5 to 2 shares. The invention has good therapeutic effect on various types of cardiovascular and cerebrovascular diseases that the blood vessel can be effectively rinsed and softened; the thrombus is defreezed; the formation of thrombosis and platelet aggregation are inhibitted; the blood viscosity is improved; the blood lipid dredging and fluency are activated; the aging cardio-cerebrovascular is renewedly vigorous; the normal supply of heart is maintained; the blood pressure decreased steadily; the blood lipid is clear; the blood sugar is decreased; the whole human body is powerful and full of energy. The clinical experiment of prior patient shows that in the condition of no recurrence in five years, the cure rate is more than ninety six percent, and the cure rate of thick blood lipid patient is more than ninety nine percent. The drug has the advantages of significant effect and no recurrence.
Description
Skill this area:
The present invention relates to a kind of is the medicine of raw material with the natural Chinese medicine, particularly relates to the medicine of a kind of prevention or treatment cardiovascular and cerebrovascular disease, belongs to medical technical field.
Background technology:
Cardiovascular and cerebrovascular disease such as coronary heart disease, cerebral thrombosis, hypertension, cerebral infarction etc. are the commonly encountered diseases in the world today, frequently-occurring disease, the sickness rate height, the disability rate height, the mortality rate height, also can cause the heart, brain, the damage of organs such as kidney, cause as brain and die suddenly, heart failure, diseases such as renal failure, it is the disease of a kind of serious harm human health and life, domestic and social life is exerted a certain influence, " the first killer " of the harm humans of being known as life, according to clinical report, sickness rate in recent years has and increases trend year by year, and in, young patient constantly increases.Therefore the medicine of developmental research prevention or treatment cardiovascular and cerebrovascular disease becomes the focus of people's research, and many scholars are in treatment and the prevention of exploring cardiovascular and cerebrovascular disease both at home and abroad.Yet clinical practice shows that the simple western medicine treatment is only cured the symptoms, not the disease, and especially side effects of pharmaceutical drugs make the patient be difficult to accept and take for a long time.Contemporary mankind's the hope that goes back to nature is strong day by day, generally wish the Chinese herb on the prevention or the treatment of natural nuisance-free, thereby for the development of Chinese medicine provides excellent opportunity, be " DANHONG ZHUSHEYE ", " the DANHONG drip liquid " that raw material is made for example by Radix Salviae Miltiorrhizae, two kinds of Chinese herbal medicine of Flos Carthami, rapid, the determined curative effect of onset aspect acute cardiovascular and cerebrovascular disease rescue, be widely used clinically, recorded in National Drug Administration's " national standard for traditional Chinese medicines compilation ".But, need the long-term prescription treatment, thereby the medication of drug administration by injection has been subjected to certain restriction in the use because cardiovascular and cerebrovascular disease is a chronic disease.Therefore press for clinically that steady quality, determined curative effect, dose are little, the prevention of taking convenience or the oral drug preparation of treatment cardiovascular and cerebrovascular disease.
In the upsurge of human " back to nature ", Chinese medicine is little with its good effect, side effect, aboundresources and extremely people's favor, increasing clinical report shows, Chinese medicine is having a good application prospect aspect prevention or the treatment cardiovascular and cerebrovascular disease, and obtain patient's approval day by day, the Chinese patent medicine of treatment cardiovascular and cerebrovascular disease many based on blood fat reducing, cholesterol reducing, blood vessel dilating, adjusting heart joint rate, improve cardiac function.In recent years, people have strengthened the research of Chinese herb on the prevention or treatment cardiovascular and cerebrovascular disease, mainly be from traditional prescription, to screen, obtained certain achievement, (application number is 97105867.9 as Chinese patent CN1200278A, denomination of invention is " a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease ") in a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease is disclosed, its prescription consists of: Herba Taxilli 6～10%, Caulis Spatholobi 6～10%, Pheretima 3～7%, Radix Salviae Miltiorrhizae 8～12%, Flos Carthami 6～10%, the Radix Astragali 6～10%, Herba Cynomorii 8～12%, Rhizoma Chuanxiong 8～12%, Radix Cyathulae 8～12%, Rhizoma Arisaematis 3～7%, Ramulus Uncariae Cum Uncis 2～6%, Bulbus Allii Macrostemonis 3～7%, Radix Rehmanniae 2～6%, Semen Strychni 3～7%.Among the Chinese patent CN1679831A (application number is 200510041653.5, denomination of invention be " a kind of oral drugs and method for making thereof for the treatment of cardiovascular and cerebrovascular disease ") a kind of medicine for the treatment of cardiovascular and cerebrovascular disease is disclosed and for example, it is to be raw material with Radix Salviae Miltiorrhizae, Flos Carthami two flavor Chinese herbal medicine, adopt low-concentration ethanol to ooze rumble method or water retting method technology respectively and extract water soluble ingredient in the two flavor Chinese medicines, again through formulated oral Chinese medicine preparation.From above these aspects as can be seen: there is very abundant pools of traditional Chinese medicine in China, has a lot of very effective Chinese medicinal formulaes, awaits further excavating and utilizing, and benefits the people.
Summary of the invention:
The object of the present invention is to provide the medicine of prevention remarkable, with low cost of a kind of advantages of simple of filling a prescription, clinical effectiveness or treatment cardiovascular and cerebrovascular disease.
The objective of the invention is to be achieved through the following technical solutions:
The medicine of a kind of prevention or treatment cardiovascular and cerebrovascular disease, make by the following natural material medicine that with the weight portion is unit, 25～30 parts of Calyx Kaki, 5～15 parts of Fructus Crataegis, 5～10 parts of Radix Salviae Miltiorrhizaes, 5～15 parts in Rhizoma Gastrodiae, 5～10 parts of Radix Notoginseng, 5～12 parts of Radix Puerariaes, 5～15 parts of Radix Polygoni Multiflori, 1～6 part of Fructus Chaenomelis, 0.5～2 part in Cornu Cervi Pantotrichum.
The medicine of described prevention or treatment cardiovascular and cerebrovascular disease is made 30 parts of Calyx Kaki, 10 parts of Fructus Crataegis, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts in Rhizoma Gastrodiae, 10 parts of Radix Notoginseng, 10 parts of Radix Puerariaes, 10 parts of Radix Polygoni Multiflori, 5 parts of Fructus Chaenomeliss, 1 part in Cornu Cervi Pantotrichum by the following natural material medicine that with the weight portion is unit.
Take by weighing each component of described weight portion, after grinding together, cross 100～120 mesh sieves,, make required pharmaceutical dosage form by medically conventional processing method.
Described pharmaceutical dosage form is a powder, or is tablet, or is pill, or is granule, or is capsule, or is oral liquid.
Positive beneficial effect of the present invention is:
1. the medicine of prevention of the present invention or treatment cardiovascular and cerebrovascular disease, based on motherland's Chinese medicine and pharmacy theory, in conjunction with clinical practice for many years, from motherland medicine treasure-house, filter out have blood circulation promoting and blood stasis dispelling, nourishing the liver and kidney, replenishing YIN and removing heat, dredging vascellum, the medicine of expellingging wind and relieving convulsion, can obviously improve fibrinolytic, improve blood viscosity, antithrombotic, the expansion peripheral blood vessel promotes collateral circulation, blood flow increasing changes diseased region and peripheral circulation, microcirculation.
In this drug component:
Calyx Kaki: puckery, sweet, sour, but blood fat reducing, the thick grade of treatment high blood viscosity disease; But clearing away lung-heat, dry, the cough-relieving of lung moistening; The cold syndrome of the stomach of can dispelling oxygen stagnates, ends singultus; Fructus Crataegi: acid, but invigorating the stomach and promoting digestion, the content of digestive acid in the increase stomach; But blood pressure lowering, the expansion peripheral blood vessel; But blood fat reducing, anti-arterial sclerosis; But arrhythmia; Can improve the heart coronary artery circulation, coronary artery dilator reduces myocardial oxygen consumption, and myocardial ischemia is had protective effect; Radix Salviae Miltiorrhizae: cold nature, bitter in the mouth, but blood circulation promoting and blood stasis dispelling, improve coronary circulation, resist myocardial ischemia; But blood pressure lowering, human body immunity improving; Can protect hepatocyte, treatment chronic hepatitis.Above-mentioned three flavor medicines are monarch drug.
Rhizoma Gastrodiae: tepor, sweet in the mouth, but cerebral blood flow increasing amount, the treatment cerebral ischemia is dizzy; Can treat hypertension, arteriosclerosis; Can treat aural vertigo; Radix Notoginseng: can stop blooding, invigorate blood circulation, blood stasis dispelling, coronary blood flow increasing reduces myocardial oxygen consumption; Can treat apoplexy, go into a coma and wait disease in silence; Can improve brain function, brain-strengthening be arranged, improve one's memory, the effect of treatment senile dementia; Also can treat diseases such as coronary heart disease, angina pectoris.Above-mentioned two flavor medicines are ministerial drug.
Radix Puerariae: flat, the sweet in the mouth of property, but expelling pathogenic factors from muscles for reducing heat, promoting the production of body fluid to quench thirst, moisten the footpath arteries and veins; Expansible heart arteria coronaria, resist myocardial ischemia treatment coronary heart disease; But the cerebral blood flow increasing amount, expansion of cerebral vascular improves diseases such as hypertension, headache, dizziness, can treat diseases such as tinnitus, numb limbs and tense tendons.Radix Polygoni Multiflori: but YIN nourishing, strong, benefiting essence-blood; But blood fat reducing, cholesterol reducing; But arteriosclerosis, defying age; Can protect the liver, hepatoprotective, improve liver function, the treatment chronic hepatitis.Above-mentioned two flavor medicines are adjuvant drug.
Fructus Chaenomelis: acidity, can remove wind damp eliminating, relaxing muscles and tendons to promote blood circulation.Cornu Cervi Pantotrichum: warm in nature, sweet-salty, but spermatogenesis benefit blood, warming the kidney to invigorate YANG; Can promote hemopoietic function, promotion erythrocyte new life, reticulocyte to increase; But sexual function improving, therapeutic hypofunction; But health invigorating improves cardiac function; Can treat anemia; Can treat have a weak heart, nervous disease such as breathe hard, strengthen mental and physical efforts, improve blood circulation.Above-mentioned two flavor medicines are messenger drug.
Above monarch, minister, assistant, make each medicine lump together use, but dredging vascellum, regulate neural, play blood circulation promoting and blood stasis dispelling altogether, the effect of heat-clearing and toxic substances removing, have the cerebrovascular permeability of alleviating and brain water content, suppress thrombosis, obvious cerebral blood flow increasing amount, thrombus, anticoagulant, reduce myocardial infarction area, reduce the blood vessel total peripheral resistance, increase the effect of heart coronary flow, can prevent or treat uncomfortable in chest, angina pectoris, insomnia, headache, the hemiplegia that the cardiovascular and cerebrovascular vessel thromboembolism causes, extremity are refused to budge, sialorrhea, mono-anesthesia, Dermatorrhexis, diseases such as sciatica are to cardiovascular and cerebrovascular disease such as apoplexy, coronary heart disease, cerebral hemorrhage, diseases such as cerebral thrombosis have unique curative effect; For the cardiovascular and cerebrovascular vessel bolt, plug, the atrophy that cause by hypertension, condense, symptom cure rate such as cold and cool after the hemianesthesia, brain, finger ignorant is high; For the blood of human body system particularly the metabolism smoothness of cardiovascular brain blood curative effect is rapidly all arranged.
2. the medicine of prevention of the present invention or treatment cardiovascular and cerebrovascular disease is the natural Chinese medicines preparation, has no side effect, and processing is simple, taking convenience, and general patients with mild need not be in hospital, and can reduce patient's spending significantly, reduces prevention or medical expense.
3. the medicine of prevention of the present invention or treatment cardiovascular and cerebrovascular disease, prescription is reasonable, and cost is low, and processing is simple, and clinical efficacy is obvious, is applicable to the patient of all kinds of decentraction cerebrovascular disease, is subjected to the favorable comment of patient and family numbers of patients deeply.
Clinical efficacy situation statistics:
1. case is selected: select that frequent increased blood pressure, dizziness, headache, feeling of fullness in the head, olic acid, insomnia are nervous, the patient of hypomnesis, spoken symptom such as unclear is as the object of observation, if the untimely treatment of above symptom, can develop into complication such as hypertension, hyperlipidemia, sclerosis of blood vessels, blood supply insufficiency, heart and brain obstruction infarction, cerebral thrombosis, cerebral hemorrhage, diabetes very soon, or else treatment, consequence can't imagine, at last deathward.
2. Therapeutic Method: to being diagnosed as the patient of cardiovascular and cerebrovascular disease, give the drug administration of prevention of the present invention or treatment cardiovascular and cerebrovascular disease, three times on the one, a 6-8 gram, one after each meal, 30 days courses of treatment.
3. points for attention:
Avoid suffering, peppery, greasy food and Folium Camelliae sinensis and tobacco and wine at period in a medicine; Hypotension and the serious careful usefulness of patients with gastric disease.
4. efficacy result:
Hyperpietic's hypertension to 170 is above, diseases such as dizzy, nervous occur, take after the course of treatment, blood pressure drops, the dizzy disappearance, continue to take 3 courses of treatment after, return to one's perfect health;
More than thick blood fat patient's the blood fat height to 10, take 2 courses of treatment after, that blood fat becomes is clear, blood fat can drop to about 2, rehabilitation is normal;
Cerebrovascular sclerosis blood supply insufficiency patient, diseases such as distending pain, dizziness appear in back brain, take 1 course of treatment after, the hindbrain distending pain obviously alleviates; After two courses of treatment, the sclerosis blood vessel begins to soften, and blood supply is normal; After 3 courses of treatment, the sclerosis blood vessel is softening fully, the complete obiteration of hindbrain distending pain;
Diseases such as that originally myocardial infarction patient presents is nervous, heart beating, pained, insomnia, after the course of treatment of taking medicine, heart rate is smooth and easy; After 2 courses of treatment, the heart is not flurried, the heart is not jumped; After 3 courses of treatment, blood supply of cardiac muscle is normal, and diseases such as nervous, heart beating, pained, insomnia disappear, and return to one's perfect health.
Cerebral thrombosis and hemiplegic patient can take care of oneself after taking 4 courses of treatment, and be spoken clear, and the ice-cold pain and numbness of extremity disappears;
After not having the people of manifest symptom to take, can fat-reducing, toxin expelling, skin care, effectively prevent the generation of hypertension and cardiovascular and cerebrovascular complication.
5. overall therapeutic outcome:
By above-mentioned clinical efficacy situation statistics as can be known: medicine of the present invention all has better curative effect to various types of cardiovascular and cerebrovascular diseases, and treating both the principal and secondary aspects of a disease can effectively clean vessel softening, dissolve thrombosis, suppress the formation of platelet aggregation and thrombosis, improve blood viscosity, it is smooth to activate the blood fat mediation, allow old and feeble cardiovascular and cerebrovascular vessel have vigor again, keep the heart regular supply, blood pressure is steadily descended, it is clear that blood fat becomes, blood glucose reduces, and it is strong, energetic to reach the human body whole body.Through last precedent patient clinical trial certificate, after most of patients was taken, under the situation that did not have recurrence in 5 years, cure rate reached more than 96%, and thick blood fat patient cure rate is up to more than 99%, have effect significantly, the magical curative effect that do not recur.
Model case:
1. high development, man, 62 years old, Hou Ji township, Wuyang County Gao Zhuan people from village, suffer from the hemiplegia that hypertension causes, babble, arm can not lifted, lower limb is being drawn on foot, come after listening the people the to introduce hospital admission at inventor place, the drug administration of treatment cardiovascular and cerebrovascular disease of the present invention, three times on the one are taken in suggestion, one time 6 gram, one after each meal, warm boiled water, 30 days courses of treatment, after treating 2 courses of treatment, return to one's perfect health, follow up a case by regular visits to after 2 years and do not have recurrence, now freedom of action such as ordinary person, clear in a minute, and mental rehabilitation is normal.
2. Ding Lanni, woman, 71 years old, Pei town and country, Yancheng Zhong Hezhai village patient, numbness of hands and feet, cerebrovascular stops up, dizziness can not be got up, half paralysed symptom, takes the medicine of treatment cardiovascular and cerebrovascular disease of the present invention, three times on the one, one time 6 gram, one after each meal, warm boiled water, 30 days courses of treatment, after treating 2 courses of treatment, return to one's perfect health.
3. open and account for moral, man, 74 years old, Xiangcheng County Jiang Zhuan township back court people from village because of heart and brain thrombosis, blood supply insufficiency cause heavy paralysis, takes the medicine of treatment cardiovascular and cerebrovascular disease of the present invention, three times on the one, one time 8 gram, one after each meal, warm boiled water, 30 days courses of treatment, treat 1 course of treatment after, reached own and can play the state that can sit, after continuing to take 3 courses of treatment, return to one's perfect health.
4. Wang Yun, woman, 51 years old, the Luohe City people, it is nervous to occur cardiopalmus in 2000, symptoms such as sensation of oppression over the chest with shortness of breath, after develop into chest pain, be diagnosed as hypertension by local hospital, coronary heart disease, blood pressure is 150/95 millimetres of mercury, treated with depressor, alleviated, in JIUYUE, 2002 chest pain increases the weight of, every day 3, sometimes continue 75 times, can alleviate in 8 minutes, with headache feeling of fullness in the head phenomenon, the medicine of taking treatment cardiovascular and cerebrovascular disease of the present invention carries out, three times on the one simultaneously, one time 8 gram, one after each meal, warm boiled water, 30 days courses of treatment, after treating 1 course of treatment, feeling of oppression and pain in the chest disappears, blood pressure 135/85 millimetres of mercury, take 2 courses of treatment again continuously after, blood pressure, it is normal that electrocardiogram recovers, blood fat is also normal, does not have recurrence so far.
The specific embodiment:
Embodiment 1: the medicine of a kind of prevention or treatment cardiovascular and cerebrovascular disease, make 25 parts of Calyx Kaki, 5 parts of Fructus Crataegis, 5 parts of Radix Salviae Miltiorrhizaes, 5 parts in Rhizoma Gastrodiae, 5 parts of Radix Notoginseng, 5 parts of Radix Puerariaes, 5 parts of Radix Polygoni Multiflori, 1 part of Fructus Chaenomelis, 0.5 part in Cornu Cervi Pantotrichum by the following natural material medicine that with the weight portion is unit.Take by weighing each component of described weight portion, after grinding together, cross 100～120 mesh sieves, make required pharmaceutical dosage form, as be powder, or be tablet, or be pill, or be granule, or be capsule.To being diagnosed as the patient of cardiovascular and cerebrovascular disease, give the drug administration of above-mentioned treatment cardiovascular and cerebrovascular disease, three times on the one, a 6-8 gram, one after each meal, 30 days courses of treatment.Generally need to prevent or treat 2～5 courses of treatment, the state of an illness just can be effectively controlled and reach the purpose of curing fully.
Embodiment 2: the processing method of present embodiment and instructions of taking are with embodiment 1, and something in common does not repeat, and difference is: the medicine of a kind of prevention or treatment cardiovascular and cerebrovascular disease, make by the following natural material medicine that with the weight portion is unit, 30 parts of Calyx Kaki, 15 parts of Fructus Crataegis, 10 parts of Radix Salviae Miltiorrhizaes, 15 parts in Rhizoma Gastrodiae, 10 parts of Radix Notoginseng, 12 parts of Radix Puerariaes, 15 parts of Radix Polygoni Multiflori, 6 parts of Fructus Chaenomeliss, 2 parts in Cornu Cervi Pantotrichum.
Embodiment 3: the processing method of present embodiment and instructions of taking are with embodiment 1, and something in common does not repeat, and difference is: the medicine of a kind of prevention or treatment cardiovascular and cerebrovascular disease, make by the following natural material medicine that with the weight portion is unit, 26 parts of Calyx Kaki, 10 parts of Fructus Crataegis, 8 parts of Radix Salviae Miltiorrhizaes, 10 parts in Rhizoma Gastrodiae, 6 parts of Radix Notoginseng, 10 parts of Radix Puerariaes, 8 parts of Radix Polygoni Multiflori, 2 parts of Fructus Chaenomeliss, 1 part in Cornu Cervi Pantotrichum.
Embodiment 4: the processing method of present embodiment and instructions of taking are with embodiment 1, and something in common does not repeat, and difference is: the medicine of a kind of prevention or treatment cardiovascular and cerebrovascular disease, make by the following natural material medicine that with the weight portion is unit, 30 parts of Calyx Kaki, 10 parts of Fructus Crataegis, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts in Rhizoma Gastrodiae, 10 parts of Radix Notoginseng, 10 parts of Radix Puerariaes, 10 parts of Radix Polygoni Multiflori, 5 parts of Fructus Chaenomeliss, 1 part in Cornu Cervi Pantotrichum.
Embodiment 5: the processing method of present embodiment and instructions of taking are with embodiment 1, and something in common does not repeat, and difference is: the medicine of a kind of prevention or treatment cardiovascular and cerebrovascular disease, make by the following natural material medicine that with the weight portion is unit, 29 parts of Calyx Kaki, 8 parts of Fructus Crataegis, 7 parts of Radix Salviae Miltiorrhizaes, 12 parts in Rhizoma Gastrodiae, 9 parts of Radix Notoginseng, 7 parts of Radix Puerariaes, 9 parts of Radix Polygoni Multiflori, 3 parts of Fructus Chaenomeliss, 1.5 parts in Cornu Cervi Pantotrichum.
Embodiment 6: the processing method of present embodiment and instructions of taking are with embodiment 1, and something in common does not repeat, and difference is: the medicine of a kind of prevention or treatment cardiovascular and cerebrovascular disease, make by the following natural material medicine that with the weight portion is unit, 27 parts of Calyx Kaki, 13 parts of Fructus Crataegis, 6 parts of Radix Salviae Miltiorrhizaes, 9 parts in Rhizoma Gastrodiae, 6 parts of Radix Notoginseng, 8 parts of Radix Puerariaes, 6 parts of Radix Polygoni Multiflori, 4 parts of Fructus Chaenomeliss, 0.5 part in Cornu Cervi Pantotrichum.
Claims (2)
- One kind the prevention or the treatment cardiovascular and cerebrovascular disease medicine, it is characterized in that: make by the following natural material medicine that with the weight portion is unit, 25～30 parts of Calyx Kaki, 5～15 parts of Fructus Crataegis, 5～10 parts of Radix Salviae Miltiorrhizaes, 5～15 parts in Rhizoma Gastrodiae, 5～10 parts of Radix Notoginseng, 5～12 parts of Radix Puerariaes, 5～15 parts of Radix Polygoni Multiflori, 1～6 part of Fructus Chaenomelis, 0.5～2 part in Cornu Cervi Pantotrichum.
- 2. the medicine of prevention according to claim 1 or treatment cardiovascular and cerebrovascular disease, it is characterized in that: make by the following natural material medicine that with the weight portion is unit, 30 parts of Calyx Kaki, 10 parts of Fructus Crataegis, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts in Rhizoma Gastrodiae, 10 parts of Radix Notoginseng, 10 parts of Radix Puerariaes, 10 parts of Radix Polygoni Multiflori, 5 parts of Fructus Chaenomeliss, 1 part in Cornu Cervi Pantotrichum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100492636A CN101244209B (en) | 2008-02-25 | 2008-02-25 | Medicament for preventing or treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100492636A CN101244209B (en) | 2008-02-25 | 2008-02-25 | Medicament for preventing or treating cardiovascular and cerebrovascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101244209A true CN101244209A (en) | 2008-08-20 |
| CN101244209B CN101244209B (en) | 2010-08-18 |
Family
ID=39945030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100492636A Expired - Fee Related CN101244209B (en) | 2008-02-25 | 2008-02-25 | Medicament for preventing or treating cardiovascular and cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101244209B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240310A (en) * | 2010-05-13 | 2011-11-16 | 郭国康 | Blood-sugar-reducing composition and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1076596C (en) * | 1998-09-18 | 2001-12-26 | 李国晓 | Tartaric acid nutritious honey capable of balancing blood pressure |
| CN100531585C (en) * | 2006-10-20 | 2009-08-26 | 张仁壮 | Persimmon leaf health tea drink and its preparing method |
-
2008
- 2008-02-25 CN CN2008100492636A patent/CN101244209B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240310A (en) * | 2010-05-13 | 2011-11-16 | 郭国康 | Blood-sugar-reducing composition and preparation method thereof |
| CN102240310B (en) * | 2010-05-13 | 2013-03-06 | 郭国康 | Blood-sugar-reducing composition and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101244209B (en) | 2010-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101254272B (en) | Medicament for promoting coronary circulation and embolism resistance | |
| CN101716242B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN103520366B (en) | Be used for the treatment of the Chinese medicine of spastic hemiplegia after stroke | |
| CN102210835B (en) | Traditional Chinese medicine for treating coronary disease | |
| CN101376016B (en) | Method for preparing Chinese medicine for treating hyperlipemia | |
| CN100540035C (en) | The Chinese herbal medicine among the people of blood pressure lowering, blood fat, blood glucose | |
| CN102441154A (en) | Chinese medicinal preparation for treating gout | |
| CN102406743B (en) | Traditional Chinese preparation for treating cerebral thrombosis | |
| CN104524342A (en) | Traditional Chinese medicine preparation for lowering high blood pressure, high blood sugar, high cholesterol, high uric acid and maintaining vigor and preparation method of plaster of traditional Chinese medicine preparation | |
| CN101244209B (en) | Medicament for preventing or treating cardiovascular and cerebrovascular diseases | |
| CN106138831A (en) | A kind of Chinese medicine composition treating cardiovascular and cerebrovascular disease and preparation method thereof | |
| CN102631607B (en) | Medicament for treating cardiovascular diseases and preparation method thereof | |
| CN102309561B (en) | Pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia | |
| CN104997956A (en) | Behcet's syndrome and treatment drug thereof | |
| CN104189714A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN104069342A (en) | Traditional Chinese medicine for treating acute heart failure | |
| CN103961603B (en) | Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels | |
| CN103520647B (en) | A kind of adjustment hyperlipidemia Chinese medicine preparation | |
| CN102755520B (en) | Chinese medicinal preparation for treating cardiovascular disease | |
| CN101961459B (en) | Oral medicament for treating hemiplegia | |
| CN102397391A (en) | Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof | |
| CN100394937C (en) | Medicine for preventing and treating cardiac and cerebral vascular diseases | |
| CN104758888A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN103251764B (en) | A kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof | |
| CN105434903A (en) | A traditional Chinese medicine preparation treating coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100818 Termination date: 20130225 |